Efstathios Kastritis, Eirini Katodritou, Sorina Badelita, Jelena Bila, Güldane Cengiz Seval, Zorica Cvetkovic, Daniel Coriu, Emmanouil Spanoudakis, Dimitra Dalampira, Aleksandra Sretenovic, Aggeliki Sevastoudi, Anca Bojan, Marko Mitrovic, Catalin Danaila, Maria Gavriatopoulou, Maria Roussou, Charalampos Charalampous, Evangelos Terpos, Meral Beksac, Meletios A Dimopoulos
{"title":"国际分期系统第二次修订版(R2-ISS)在真实世界队列中对多发性骨髓瘤总生存期的验证:巴尔干骨髓瘤研究小组(BMSG)的分析。","authors":"Efstathios Kastritis, Eirini Katodritou, Sorina Badelita, Jelena Bila, Güldane Cengiz Seval, Zorica Cvetkovic, Daniel Coriu, Emmanouil Spanoudakis, Dimitra Dalampira, Aleksandra Sretenovic, Aggeliki Sevastoudi, Anca Bojan, Marko Mitrovic, Catalin Danaila, Maria Gavriatopoulou, Maria Roussou, Charalampos Charalampous, Evangelos Terpos, Meral Beksac, Meletios A Dimopoulos","doi":"10.1080/10428194.2024.2391900","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":18047,"journal":{"name":"Leukemia & Lymphoma","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).\",\"authors\":\"Efstathios Kastritis, Eirini Katodritou, Sorina Badelita, Jelena Bila, Güldane Cengiz Seval, Zorica Cvetkovic, Daniel Coriu, Emmanouil Spanoudakis, Dimitra Dalampira, Aleksandra Sretenovic, Aggeliki Sevastoudi, Anca Bojan, Marko Mitrovic, Catalin Danaila, Maria Gavriatopoulou, Maria Roussou, Charalampos Charalampous, Evangelos Terpos, Meral Beksac, Meletios A Dimopoulos\",\"doi\":\"10.1080/10428194.2024.2391900\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":18047,\"journal\":{\"name\":\"Leukemia & Lymphoma\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Leukemia & Lymphoma\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/10428194.2024.2391900\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Leukemia & Lymphoma","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10428194.2024.2391900","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
Validation of the second revision of the international staging system (R2-ISS) for overall survival in multiple myeloma in a real-world cohort: an analysis by the Balkan myeloma study group (BMSG).
期刊介绍:
Leukemia & Lymphoma in its fourth decade continues to provide an international forum for publication of high quality clinical, translational, and basic science research, and original observations relating to all aspects of hematological malignancies. The scope ranges from clinical and clinico-pathological investigations to fundamental research in disease biology, mechanisms of action of novel agents, development of combination chemotherapy, pharmacology and pharmacogenomics as well as ethics and epidemiology. Submissions of unique clinical observations or confirmatory studies are considered and published as Letters to the Editor